drugset / Trial / NCT03805438

ED90 of 3% Chloroprocaine for Cervical Cerclage

NCT03805438

Phase 4 Completed 47 enrolled Duke University University of Arkansas · collab
NaSequentialOpen-labelDiagnostic

Summary

The aim of this study is to identify the dose of intrathecal (IT) chloroprocaine that provides effective anesthesia in 90% of patients undergoing elective cerclage placement (intraoperative analgesic supplementation not required).

Timeline

Start
2019-02-07
Primary completion
2020-10-23
Completion
2020-10-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloroprocaine Other / unclassified 45 mg Intrathecal